How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

776 results for

Pyoderma Gangrenosum

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

2. Risk of Developing Pyoderma Gangrenosum after Procedures in Patients with a Known History of Pyoderma Gangrenosum - A Retrospective Analysis. Full Text available with Trip Pro

Risk of Developing Pyoderma Gangrenosum after Procedures in Patients with a Known History of Pyoderma Gangrenosum - A Retrospective Analysis. The risk of postoperative pyoderma gangrenosum (PG) in patients with a known history of PG is unknown.To quantify risk and identify patient- and/or procedure-related risk factors for postsurgical recurrence or exacerbation of PG in patients with a known history of PG.We retrospectively evaluated the likelihood of postsurgical recurrence or exacerbation

2017 Journal of American Academy of Dermatology

3. Comparison of Clinical Features between Pyoderma Gangrenosum Concomitant by Inflammatory Bowel Disease and Idiopathic Pyoderma Gangrenosum Full Text available with Trip Pro

Comparison of Clinical Features between Pyoderma Gangrenosum Concomitant by Inflammatory Bowel Disease and Idiopathic Pyoderma Gangrenosum Pyoderma gangrenosum (PG) is a rare neutrophilic dermatosis that is highly associated with inflammatory bowel disease (IBD). Certain PG patients with no systemic disorders have been diagnosed with idiopathic PG. This study sought to clarify the difference between PG with IBD and idiopathic PG based on clinical features, laboratory tests

2017 Chinese medical journal

4. Pyoderma gangrenosum after cesarean section treated with skin graft: A case report. Full Text available with Trip Pro

Pyoderma gangrenosum after cesarean section treated with skin graft: A case report. Pyoderma gangrenosum (PG) is a rare skin disease. Pregnancy is a unique physiological condition. Here we report a rare case of PG after cesarean section.A 32-year-old female presented with wound breakdown 1 day after cesarean section, with progression to a skin ulcer and no response to antibiotic therapy.We experienced a case of PG after cesarean section. This was initially misdiagnosed as a wound infection

2019 Medicine

5. Comment on 'Bullous pyoderma gangrenosum secondary to underlying multiple myeloma: treated with ciclosporin'. (Abstract)

Comment on 'Bullous pyoderma gangrenosum secondary to underlying multiple myeloma: treated with ciclosporin'. 31162845 2019 07 08 1365-2230 2019 Jun 04 Clinical and experimental dermatology Clin. Exp. Dermatol. Comment on 'Bullous pyoderma gangrenosum secondary to underlying multiple myeloma: treated with ciclosporin'. 10.1111/ced.14019 Mathivanan B R BR https://orcid.org/0000-0002-5324-1559 Department of Dermatology, Venereology and Leprology, All India Institute of Medical Sciences, Jodhpur

2019 Clinical & Experimental Dermatology

6. Pyoderma gangrenosum misdiagnosed as necrotising fasciitis or a real association between the two? (Abstract)

Pyoderma gangrenosum misdiagnosed as necrotising fasciitis or a real association between the two? 30897232 2019 10 25 1468-3083 33 8 2019 08 Journal of the European Academy of Dermatology and Venereology : JEADV J Eur Acad Dermatol Venereol Pyoderma gangrenosum misdiagnosed as necrotising fasciitis or a real association between the two? e305-e306 10.1111/jdv.15585 Cirotteau P P Department of Dermatology, Hôpital Saint André, University Hospital Bordeaux, Bordeaux, France. Heron-Mermin D D

2019 Journal of the European Academy of Dermatology and Venereology

7. Disseminated sporotrichosis following iatrogenic immunosuppression for suspected pyoderma gangrenosum. (Abstract)

Disseminated sporotrichosis following iatrogenic immunosuppression for suspected pyoderma gangrenosum. Sporotrichosis is an infection caused by the dimorphic fungus Sporothrix schenckii and related species that often arises from traumatic inoculation of inhabited soil and organic debris into skin. The infection is usually limited to the skin in immunocompetent patients, usually as lymphocutaneous sporotrichosis. Accurate diagnosis rests on clinical data and culture, and might be facilitated (...) by biopsy identification of suppurative and granulomatous inflammation with fungal elements. In this Grand Round, we present a dramatic case of cutaneous sporotrichosis initially presented with an atypical large ulcer without associated lymphocutaneous spread, clinically mimicking pyoderma gangrenosum, and subsequently progressed to disseminated sporotrichosis in the setting of iatrogenic immunosuppression. We further review the clinical features, risk factors, and treatment of these disseminated

2019 Lancet infectious diseases

8. Prevalence estimates for pyoderma gangrenosum in the United States: An age- and sex-adjusted population analysis. (Abstract)

Prevalence estimates for pyoderma gangrenosum in the United States: An age- and sex-adjusted population analysis. The disease burden of pyoderma gangrenosum (PG) is poorly understood.To determine standardized overall and age-, sex-, and race-specific prevalence estimates for PG among adults in the United States.Cross-sectional analysis of 1971 patients with PG identified using electronic health records data from a diverse population-based sample of more than 58 million patients.The age- and sex

2019 Journal of American Academy of Dermatology

9. Paraneoplastic pyoderma gangrenosum in solid organ malignancy: a literature review. (Abstract)

Paraneoplastic pyoderma gangrenosum in solid organ malignancy: a literature review. Pyoderma gangrenosum (PG) is a rare destructive, ulcerative, and inflammatory cutaneous disease. PG can be associated with inflammatory bowel disease (IBD), arthritis, autoinflammatory syndromes, and hematological malignancies. Multiple reports in the literature have found an association between PG and solid organ tumors. This article provides a summary and review of PG in patients with solid organ malignancies (...) . We performed a PubMed search using the terms pyoderma gangrenosum, paraneoplastic pyoderma gangrenosum, cancer, malignancy, tumor, and solid organ malignancy. Out of 529 papers screened, 19 relevant cases were included that reported patients above the age of 12 years old with antecedent, coincident, or subsequent occurrence of PG in association with a solid organ malignancy. The most common malignancies associated with PG were found in the breast (n = 6, 31.6%). In a majority of the cases

2019 International Journal of Dermatology

10. Pyoderma gangrenosum in a patient with lipoid proteinosis (Urbach-Wiethe disease). (Abstract)

Pyoderma gangrenosum in a patient with lipoid proteinosis (Urbach-Wiethe disease). 30868669 2019 10 25 1468-3083 33 8 2019 08 Journal of the European Academy of Dermatology and Venereology : JEADV J Eur Acad Dermatol Venereol Pyoderma gangrenosum in a patient with lipoid proteinosis (Urbach-Wiethe disease). e293-e295 10.1111/jdv.15564 Pilz A C AC Department of Dermatology and Allergy, Technical University of Munich, Biedersteiner Straße 29, Munich, 80802, Germany. Zink A A 0000-0001-9313-6588

2019 Journal of the European Academy of Dermatology and Venereology

11. Absence of donor-site pathergy following fractional autologous full-thickness skin grafting in pyoderma gangrenosum. (Abstract)

Absence of donor-site pathergy following fractional autologous full-thickness skin grafting in pyoderma gangrenosum. Pyoderma gangrenosum (PG) is an uncommon inflammatory skin disorder, often associated with arthritis, inflammatory bowel disease, and/or hematologic malignancies [1]. A classic feature of PG is the development or worsening of lesions at areas that experience trauma, also known as pathergy. Autologous skin grafting may be challenging in these patients due to the potential

2019 British Journal of Dermatology

12. Clinical factors influencing the response to intravenous immunoglobulin treatment in cases of treatment-resistant pyoderma gangrenosum. (Abstract)

Clinical factors influencing the response to intravenous immunoglobulin treatment in cases of treatment-resistant pyoderma gangrenosum. Pyoderma gangrenosum (PG) is a neutrophilic disorder which classically presents as chronic, painful ulcers on the lower extremities. There is evidence supporting a potential role for intravenous immunoglobulin (IVIG) as adjuvant therapy for treatment-resistant cases; however, it is unclear which patients will most benefit from this modality of treatment (...) - an especially important consideration given the cost per infusion ($5000-$10,000). Thus, we sought to identify the clinical characteristics of patients with refractory PG lesions who demonstrated complete healing when IVIG was incorporated into the therapeutic plan.We performed a literature search of PubMed/MEDLINE and Embase using the keywords 'pyoderma gangrenosum' and 'IVIG'. We also added four institutional cases. Descriptive statistics were used to analyze the data. Significance was set at p < .05.We

2019 Journal of Dermatological Treatment

13. Overall and Subgroup Prevalence of Pyoderma Gangrenosum Among Patients with Hidradenitis Suppurativa: a population based analysis in the United States. (Abstract)

Overall and Subgroup Prevalence of Pyoderma Gangrenosum Among Patients with Hidradenitis Suppurativa: a population based analysis in the United States. Hidradenitis suppurativa (HS) and pyoderma gangrenosum (PG) are reported to coexist, although prevalence of PG among HS patients has not been systematically evaluated.To evaluate PG prevalence among HS patients.Cross-sectional analysis of adults with PG among HS and non-HS patients using electronic health records data from a population-based

2019 Journal of the American Academy of Dermatology

14. Tofacitinib for the Treatment of Pyoderma Gangrenosum. Full Text available with Trip Pro

Tofacitinib for the Treatment of Pyoderma Gangrenosum. Pyoderma gangrenosum (PG) is a difficult-to-treat inflammatory skin condition that affects inflammatory bowel disease (IBD) patients. There is no standardized approach for PG treatment.1 We report the results of 3 patients with Crohn's disease (CD) and refractory PG who had failed several therapies with biologics and were started on tofacitinib for severe inflammatory arthritis with resolution of their PG.Copyright © 2018 AGA Institute

2018 Clinical Gastroenterology and Hepatology

15. Assessing the Severity of Pyoderma Gangrenosum - A Need for Validated Measurement Tools. Full Text available with Trip Pro

Assessing the Severity of Pyoderma Gangrenosum - A Need for Validated Measurement Tools. 30171689 2019 01 03 1365-2133 180 1 2019 Jan The British journal of dermatology Br. J. Dermatol. Assessing the severity of pyoderma gangrenosum: a need for validated measurement tools. 217-218 10.1111/bjd.17122 Dorrell D N DN http://orcid.org/0000-0002-3334-8391 Department of Dermatology, Center for Dermatology Research, Wake Forest School of Medicine, Winston-Salem, NC, U.S.A. Huang W W WW Department

2018 British Journal of Dermatology

16. Two case reports of pyoderma gangrenosum and systemic lupus erythematosus: A rare but nonfortuitous association? Full Text available with Trip Pro

Two case reports of pyoderma gangrenosum and systemic lupus erythematosus: A rare but nonfortuitous association? Pyoderma gangrenosum (PG), like other neutrophilic dermatosis, may be associated with a variety of systemic disorders including inflammatory bowel diseases, rheumatoid arthritis, and hematologic disorders. Conversely, the association between PG and systemic lupus erythematosus (SLE) has rarely been reported.We report here 2 cases of this association.The first case involves a 32-year

2018 Medicine

17. A Case of the Co-Existence of Subcorneal Pustular Dermatosis and Pyoderma Gangrenosum and a Review of the Literature Full Text available with Trip Pro

A Case of the Co-Existence of Subcorneal Pustular Dermatosis and Pyoderma Gangrenosum and a Review of the Literature Subcorneal pustular dermatosis, also known as Sneddon-Wilkinson disease, can be classified as one of the neutrophilic dermatoses together with pyoderma gangrenosum. The development of both SPD and PG in the same patient has rarely been reported and may be a strong indicator of IgA dysglobulinemia.We report the case of a 34-year-old woman with a 2-year history of relapsing (...) pustular eruptions mainly affecting the abdomen, gluteus region, elbows, and the extremities. Four years after the onset of subcorneal pustular dermatosis (SPD), she developed pyoderma gangrenosum (PG) on her right hand. In literature, the coexistence of SPD and PG in the same patient has already been described. This co-occurrence might indicate a certain predisposition for immune dysregulation.Although the two NDs are often associated with systemic diseases, these patients should be followed up

2018 Open access Macedonian journal of medical sciences

18. Central retinal arterial occlusion in a patient with pyoderma gangrenosum Full Text available with Trip Pro

Central retinal arterial occlusion in a patient with pyoderma gangrenosum A 74-year-old male presented to us with a history of vision loss for 36 hours in the right eye (RE). The RE had a visual acuity of hand movements. The fundus revealed a pale retina, cattle tracking in the retinal vessels, and a cherry-red spot at the macula. The patient was a known case of pyoderma gangrenosum (PG) and had received intravenous methylprednisolone and cyclophosphamide at the onset of visual symptoms

2018 Indian journal of ophthalmology

19. Pyoderma gangrenosum with its subtype affecting oral mucosa pyostomatitis vegetans following skin melanoma surgical excision in a patient with ulcerative colitis: a case report Full Text available with Trip Pro

Pyoderma gangrenosum with its subtype affecting oral mucosa pyostomatitis vegetans following skin melanoma surgical excision in a patient with ulcerative colitis: a case report 29760625 2018 11 14 1642-395X 35 2 2018 Apr Postepy dermatologii i alergologii Postepy Dermatol Alergol Pyoderma gangrenosum with its subtype affecting oral mucosa pyostomatitis vegetans following skin melanoma surgical excision in a patient with ulcerative colitis: a case report. 212-216 10.5114/ada.2018.75246 Niezgoda

2018 Advances in Dermatology and Allergology/Postȩpy Dermatologii i Alergologii

20. A Case of Pyoderma Gangrenosum with Myelodysplastic Syndrome Full Text available with Trip Pro

A Case of Pyoderma Gangrenosum with Myelodysplastic Syndrome 29853768 2018 11 14 1013-9087 30 3 2018 Jun Annals of dermatology Ann Dermatol A Case of Pyoderma Gangrenosum with Myelodysplastic Syndrome. 392-393 10.5021/ad.2018.30.3.392 Ha Jae Won JW Department of Dermatology, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea. Hahm Ji Eun JE Department of Dermatology, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea. Kim Kang Su

2018 Annals of dermatology

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>